HealiRNA
Latest round
- Angel
Last raised
- Sep 2021
Total raised
- Undisclosed
Investors
- 3
About HealiRNA
Established in 2021 and based in Suzhou, China, HealiRNA operates as a mRNA drug technology production platform that provides infectious disease vaccines, tumor vaccines, cell therapy and protein substitution based on mRNA technology. In March 2021, the company cooperates with Soochow University and Suzhou Nano Institute of Chinese Academy of Sciences. In April 2022, it was awarded as the national science and technology SMEs. The company based on mRNA technology developing infectious disease vaccines, tumor vaccines, cell therapy and protein substitution. It provides nucleic acid drug development and production platform, including cell like system (CLS) development platform, superfluidic production platform and mRNA design and synthesis platform. Products include Pfizer, BioNTech and Moderna new crown mRNA vaccine. The company generates revenue by providing mRNA drug R&D services, product pipelines cooperation, and selling its self-developed mRNA-based drugs for both human and animal applications in the future.
Who invested in HealiRNA
3 investors across 1 round
See all investors in HealiRNA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Sep 22, 2021
Amount
Undisclosed
Investors
Questions about HealiRNA
Who invested in HealiRNA?
HealiRNA has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HealiRNA raised?
HealiRNA has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HealiRNA last raise money?
HealiRNA's most recent round on record is a Angel, in Sep 2021.
What does HealiRNA do?
Established in 2021 and based in Suzhou, China, HealiRNA operates as a mRNA drug technology production platform that provides infectious disease vaccines, tumor vaccines, cell therapy and protein substitution based on mRNA technology.
Where is HealiRNA headquartered?
HealiRNA is headquartered in Suzhou, China.
Which VCs invest in companies like HealiRNA?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at HealiRNA's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like HealiRNA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.